Brief: Median Technologies Announces Positive Preliminary Results About Ibiopsy® Clinical Development Plan

Median Technologies SA

17/06/2020 16:52

June 17 (Reuters) - MEDIAN TECHNOLOGIES SA  ALMDT.PA :
    * ENCOURAGING PRELIMINARY RESULTS ABOUT THE IBIOPSY®
CLINICAL
DEVELOPMENT PLAN ON LIVER CANCER AND THE TECHNOLOGICAL METHODS
THEREIN
    * DEVELOPMENT OF A FIBROSIS BIOMARKER FROM CT SCAN IMAGING
    * A BETTER PERFORMING BIOMARKER COMPARED TO EXISTING IMAGING
BIOMARKERS
    * IBIOPSY® DEVELOPMENT PROGRAM SUPPORTED BY EUROPEAN
INVESTMENT
BANK (EIB) THROUGH FINANCIAL LOAN OF EUR 35 MILLION UNDER
JUNCKER PLAN, EUROPEAN FUND FOR STRATEGIC INVESTMENTS

Source text for Eikon:  ID:nBw9Ywm3ca 
Further company coverage:  ALMDT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))